Click for best price
Passive Transdermal Drug Delivery Market Size, Share 2022
Market Analysis and Insights: Global Passive Transdermal Drug Delivery Market
The global Passive Transdermal Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Passive Transdermal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Passive Transdermal Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Passive Transdermal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Passive Transdermal Drug Delivery market.
Global Passive Transdermal Drug Delivery Scope and Market Size
Passive Transdermal Drug Delivery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Passive Transdermal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Passive Transdermal Drug Delivery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Microfluidics
Smart Pill Technology (SPT)
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Passive Transdermal Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Passive Transdermal Drug Delivery, with price, sales, revenue, and global market share of Passive Transdermal Drug Delivery from 2019 to 2022.
Chapter 3, the Passive Transdermal Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Transdermal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Passive Transdermal Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Passive Transdermal Drug Delivery.
Chapter 13, 14, and 15, to describe Passive Transdermal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Passive Transdermal Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Passive Transdermal Drug Delivery Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Passive Transdermal Drug Delivery Product Introduction
1.2 Global Passive Transdermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Passive Transdermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Passive Transdermal Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Passive Transdermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Passive Transdermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Passive Transdermal Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Passive Transdermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Passive Transdermal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Passive Transdermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Passive Transdermal Drug Delivery Market Dynamics
1.5.1 Passive Transdermal Drug Delivery Industry Trends
1.5.2 Passive Transdermal Drug Delivery Market Drivers
1.5.3 Passive Transdermal Drug Delivery Market Challenges
1.5.4 Passive Transdermal Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Passive Transdermal Drug Delivery Market Segment by Type
2.1.1 Microfluidics
2.1.2 Smart Pill Technology (SPT)
2.2 Global Passive Transdermal Drug Delivery Market Size by Type
2.2.1 Global Passive Transdermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Passive Transdermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Passive Transdermal Drug Delivery Market Size by Type
2.3.1 United States Passive Transdermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Passive Transdermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Passive Transdermal Drug Delivery Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Passive Transdermal Drug Delivery Market Size by Application
3.2.1 Global Passive Transdermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Passive Transdermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Passive Transdermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Passive Transdermal Drug Delivery Market Size by Application
3.3.1 United States Passive Transdermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Passive Transdermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Passive Transdermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Passive Transdermal Drug Delivery Competitor Landscape by Company
4.1 Global Passive Transdermal Drug Delivery Market Size by Company
4.1.1 Top Global Passive Transdermal Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Passive Transdermal Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Passive Transdermal Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Passive Transdermal Drug Delivery Concentration Ratio (CR)
4.2.1 Passive Transdermal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Passive Transdermal Drug Delivery in 2021
4.2.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Passive Transdermal Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Passive Transdermal Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Passive Transdermal Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Passive Transdermal Drug Delivery Market Size by Company
4.5.1 Top Passive Transdermal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Passive Transdermal Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Passive Transdermal Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Passive Transdermal Drug Delivery Market Size by Region
5.1 Global Passive Transdermal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Passive Transdermal Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Passive Transdermal Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Passive Transdermal Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Passive Transdermal Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Passive Transdermal Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Passive Transdermal Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 3M
7.1.1 3M Corporation Information
7.1.2 3M Description and Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 3M Passive Transdermal Drug Delivery Products Offered
7.1.5 3M Recent Development
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Corporation Information
7.2.2 Actavis, Inc. Description and Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Products Offered
7.2.5 Actavis, Inc. Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Corporation Information
7.3.2 Bayer AG Description and Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer AG Passive Transdermal Drug Delivery Products Offered
7.3.5 Bayer AG Recent Development
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporation Information
7.4.2 Boehringer Ingelheim GmbH Description and Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Products Offered
7.4.5 Boehringer Ingelheim GmbH Recent Development
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Corporation Information
7.5.2 Corium International, Inc. Description and Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Products Offered
7.5.5 Corium International, Inc. Recent Development
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Corporation Information
7.6.2 Echo Therapeutics, Inc. Description and Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Products Offered
7.6.5 Echo Therapeutics, Inc. Recent Development
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Corporation Information
7.7.2 GlaxoSmithKline plc Description and Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Products Offered
7.7.5 GlaxoSmithKline plc Recent Development
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Products Offered
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
7.9 Mylan N.V.
7.9.1 Mylan N.V. Corporation Information
7.9.2 Mylan N.V. Description and Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Products Offered
7.9.5 Mylan N.V. Recent Development
7.10 Novartis AG
7.10.1 Novartis AG Corporation Information
7.10.2 Novartis AG Description and Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Novartis AG Passive Transdermal Drug Delivery Products Offered
7.10.5 Novartis AG Recent Development
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Corporation Information
7.11.2 Noven Pharmaceuticals, Inc. Description and Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Products Offered
7.11.5 Noven Pharmaceuticals, Inc. Recent Development
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Corporation Information
7.12.2 Transdermal Corp. Description and Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Transdermal Corp. Products Offered
7.12.5 Transdermal Corp. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Passive Transdermal Drug Delivery Industry Chain Analysis
8.2 Passive Transdermal Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Passive Transdermal Drug Delivery Distributors
8.3 Passive Transdermal Drug Delivery Production Mode & Process
8.4 Passive Transdermal Drug Delivery Sales and Marketing
8.4.1 Passive Transdermal Drug Delivery Sales Channels
8.4.2 Passive Transdermal Drug Delivery Distributors
8.5 Passive Transdermal Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Passive Transdermal Drug Delivery CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Passive Transdermal Drug Delivery Market Trends
Table 3. Passive Transdermal Drug Delivery Market Drivers
Table 4. Passive Transdermal Drug Delivery Market Challenges
Table 5. Passive Transdermal Drug Delivery Market Restraints
Table 6. Global Passive Transdermal Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Passive Transdermal Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Passive Transdermal Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Passive Transdermal Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Passive Transdermal Drug Delivery Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Passive Transdermal Drug Delivery Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturer, 2017-2022
Table 13. Global Passive Transdermal Drug Delivery Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Passive Transdermal Drug Delivery Sales Share by Manufacturer, 2017-2022
Table 15. Global Passive Transdermal Drug Delivery Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Transdermal Drug Delivery as of 2021)
Table 18. Top Players of Passive Transdermal Drug Delivery in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Passive Transdermal Drug Delivery Product Type
Table 20. Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Passive Transdermal Drug Delivery Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Passive Transdermal Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Passive Transdermal Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Passive Transdermal Drug Delivery Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Passive Transdermal Drug Delivery Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Passive Transdermal Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Passive Transdermal Drug Delivery Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Passive Transdermal Drug Delivery Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Passive Transdermal Drug Delivery Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Passive Transdermal Drug Delivery Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Passive Transdermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Passive Transdermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Passive Transdermal Drug Delivery Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Passive Transdermal Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Passive Transdermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Passive Transdermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Passive Transdermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Passive Transdermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Passive Transdermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Passive Transdermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. 3M Corporation Information
Table 43. 3M Description and Business Overview
Table 44. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. 3M Passive Transdermal Drug Delivery Product
Table 46. 3M Recent Development
Table 47. Actavis, Inc. Corporation Information
Table 48. Actavis, Inc. Description and Business Overview
Table 49. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Actavis, Inc. Product
Table 51. Actavis, Inc. Recent Development
Table 52. Bayer AG Corporation Information
Table 53. Bayer AG Description and Business Overview
Table 54. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bayer AG Product
Table 56. Bayer AG Recent Development
Table 57. Boehringer Ingelheim GmbH Corporation Information
Table 58. Boehringer Ingelheim GmbH Description and Business Overview
Table 59. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Boehringer Ingelheim GmbH Product
Table 61. Boehringer Ingelheim GmbH Recent Development
Table 62. Corium International, Inc. Corporation Information
Table 63. Corium International, Inc. Description and Business Overview
Table 64. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Corium International, Inc. Product
Table 66. Corium International, Inc. Recent Development
Table 67. Echo Therapeutics, Inc. Corporation Information
Table 68. Echo Therapeutics, Inc. Description and Business Overview
Table 69. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Echo Therapeutics, Inc. Product
Table 71. Echo Therapeutics, Inc. Recent Development
Table 72. GlaxoSmithKline plc Corporation Information
Table 73. GlaxoSmithKline plc Description and Business Overview
Table 74. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. GlaxoSmithKline plc Product
Table 76. GlaxoSmithKline plc Recent Development
Table 77. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 78. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 79. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product
Table 81. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table 82. Mylan N.V. Corporation Information
Table 83. Mylan N.V. Description and Business Overview
Table 84. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Mylan N.V. Product
Table 86. Mylan N.V. Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. Noven Pharmaceuticals, Inc. Corporation Information
Table 93. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 94. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Noven Pharmaceuticals, Inc. Product
Table 96. Noven Pharmaceuticals, Inc. Recent Development
Table 97. Transdermal Corp. Corporation Information
Table 98. Transdermal Corp. Description and Business Overview
Table 99. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Transdermal Corp. Product
Table 101. Transdermal Corp. Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Passive Transdermal Drug Delivery Customers List
Table 105. Passive Transdermal Drug Delivery Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Passive Transdermal Drug Delivery Product Picture
Figure 2. Global Passive Transdermal Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Passive Transdermal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 4. Global Passive Transdermal Drug Delivery Sales 2017-2028 (K Units)
Figure 5. United States Passive Transdermal Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Passive Transdermal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 7. United States Passive Transdermal Drug Delivery Sales 2017-2028 (K Units)
Figure 8. United States Passive Transdermal Drug Delivery Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Passive Transdermal Drug Delivery Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Passive Transdermal Drug Delivery Report Years Considered
Figure 11. Product Picture of Microfluidics
Figure 12. Product Picture of Smart Pill Technology (SPT)
Figure 13. Global Passive Transdermal Drug Delivery Market Share by Type in 2022 & 2028
Figure 14. Global Passive Transdermal Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Passive Transdermal Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Passive Transdermal Drug Delivery Sales by Type (2017-2028) & (K Units)
Figure 17. Global Passive Transdermal Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Passive Transdermal Drug Delivery Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Passive Transdermal Drug Delivery Market Share by Type in 2022 & 2028
Figure 20. United States Passive Transdermal Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Passive Transdermal Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Passive Transdermal Drug Delivery Sales by Type (2017-2028) & (K Units)
Figure 23. United States Passive Transdermal Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Passive Transdermal Drug Delivery Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Clinic
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Others
Figure 28. Global Passive Transdermal Drug Delivery Market Share by Application in 2022 & 2028
Figure 29. Global Passive Transdermal Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Passive Transdermal Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Passive Transdermal Drug Delivery Sales by Application (2017-2028) & (K Units)
Figure 32. Global Passive Transdermal Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Passive Transdermal Drug Delivery Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Passive Transdermal Drug Delivery Market Share by Application in 2022 & 2028
Figure 35. United States Passive Transdermal Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Passive Transdermal Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Passive Transdermal Drug Delivery Sales by Application (2017-2028) & (K Units)
Figure 38. United States Passive Transdermal Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Passive Transdermal Drug Delivery Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Passive Transdermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Passive Transdermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Passive Transdermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Passive Transdermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Passive Transdermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Passive Transdermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Passive Transdermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Passive Transdermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Passive Transdermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Passive Transdermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Passive Transdermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Passive Transdermal Drug Delivery Value Chain
Figure 74. Passive Transdermal Drug Delivery Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
